Rinvoq vs Xeljanz: Side-by-Side Comparison
Quick answer: Rinvoq and Xeljanz are both jak inhibitor used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Rinvoq | Xeljanz |
|---|---|---|
| Drug class | JAK inhibitor | JAK inhibitor |
| ATC code | L04AF03 | L04AF01 |
| Primary indications | Rheumatoid arthritis, Atopic dermatitis | Rheumatoid arthritis, Psoriatic arthritis |
| Mechanism | Brand name for upadacitinib; selective Janus kinase 1 (JAK1) inhibitor that modulates cytokine signaling | Selective inhibitor of Janus kinases (primarily JAK1 and JAK3) that blocks cytokine signaling involved in inflammation |
| Common dose | 15 mg once daily (up to 45 mg in some indications) | 5 mg twice daily or 11 mg extended-release once daily |
| Detail page | Rinvoq details → | Xeljanz details → |
How to choose between Rinvoq and Xeljanz
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All JAK inhibitor on iMedic · Rinvoq full details · Xeljanz full details
Frequently asked questions
Is Rinvoq better than Xeljanz?
Neither is universally 'better.' They are both jak inhibitor with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Rinvoq to Xeljanz?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Rinvoq and Xeljanz have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Rinvoq and Xeljanz available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.